256 related articles for article (PubMed ID: 23812774)
1. Anti-melanogenic effect of (Z)-5-(2,4-dihydroxybenzylidene) thiazolidine-2,4-dione, a novel tyrosinase inhibitor.
Kim SH; Ha YM; Moon KM; Choi YJ; Park YJ; Jeong HO; Chung KW; Lee HJ; Chun P; Moon HR; Chung HY
Arch Pharm Res; 2013 Oct; 36(10):1189-97. PubMed ID: 23812774
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effect of a synthetic compound, (Z)-5-(2,4-dihydroxybenzylidene) thiazolidine-2,4-dione (MHY498), on nitric oxide-induced melanogenesis.
Kim SH; Choi YJ; Moon KM; Lee HJ; Woo Y; Chung KW; Jung Y; Kim S; Chun P; Byun Y; Ha YM; Moon HR; Chung HY
Bioorg Med Chem Lett; 2013 Aug; 23(15):4332-5. PubMed ID: 23806552
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of in vitro and in vivo anti-melanogenic activity of a newly synthesized strong tyrosinase inhibitor (E)-3-(2,4 dihydroxybenzylidene)pyrrolidine-2,5-dione (3-DBP).
Chung KW; Park YJ; Choi YJ; Park MH; Ha YM; Uehara Y; Yoon JH; Chun P; Moon HR; Chung HY
Biochim Biophys Acta; 2012 Jul; 1820(7):962-9. PubMed ID: 22498140
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as novel tyrosinase inhibitors.
Ha YM; Park YJ; Kim JA; Park D; Park JY; Lee HJ; Lee JY; Moon HR; Chung HY
Eur J Med Chem; 2012 Mar; 49():245-52. PubMed ID: 22301213
[TBL] [Abstract][Full Text] [Related]
5. Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma.
Sato K; Toriyama M
J Dermatol Sci; 2009 Feb; 53(2):140-5. PubMed ID: 19013771
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a novel tyrosinase inhibitor, (2RS,4R)-2-(2,4-dihydroxyphenyl)thiazolidine-4-carboxylic acid (MHY384).
Han YK; Park YJ; Ha YM; Park D; Lee JY; Lee N; Yoon JH; Moon HR; Chung HY
Biochim Biophys Acta; 2012 Apr; 1820(4):542-9. PubMed ID: 22251576
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and evaluation of (E)-N-substituted benzylidene-aniline derivatives as tyrosinase inhibitors.
Bae SJ; Ha YM; Park YJ; Park JY; Song YM; Ha TK; Chun P; Moon HR; Chung HY
Eur J Med Chem; 2012 Nov; 57():383-90. PubMed ID: 23149255
[TBL] [Abstract][Full Text] [Related]
8. Ficus deltoidea (Mas cotek) extract exerted anti-melanogenic activity by preventing tyrosinase activity in vitro and by suppressing tyrosinase gene expression in B16F1 melanoma cells.
Oh MJ; Hamid MA; Ngadiran S; Seo YK; Sarmidi MR; Park CS
Arch Dermatol Res; 2011 Apr; 303(3):161-70. PubMed ID: 20981431
[TBL] [Abstract][Full Text] [Related]
9. Aqueous fraction from Cuscuta japonica seed suppresses melanin synthesis through inhibition of the p38 mitogen-activated protein kinase signaling pathway in B16F10 cells.
Jang JY; Kim HN; Kim YR; Choi YH; Kim BW; Shin HK; Choi BT
J Ethnopharmacol; 2012 May; 141(1):338-44. PubMed ID: 22414478
[TBL] [Abstract][Full Text] [Related]
10. Anti-melanogenesis of novel kojic acid derivatives in B16F10 cells and zebrafish.
Chen YM; Su WC; Li C; Shi Y; Chen QX; Zheng J; Tang DL; Chen SM; Wang Q
Int J Biol Macromol; 2019 Feb; 123():723-731. PubMed ID: 30414415
[TBL] [Abstract][Full Text] [Related]
11. Glycine hydroxamate inhibits tyrosinase activity and melanin contents through downregulating cAMP/PKA signaling pathways.
Lin YS; Wu WC; Lin SY; Hou WC
Amino Acids; 2015 Mar; 47(3):617-25. PubMed ID: 25501504
[TBL] [Abstract][Full Text] [Related]
12. Antimelanogenic activity of 3,4-dihydroxyacetophenone: inhibition of tyrosinase and MITF.
Kim YJ; No JK; Lee JS; Kim MS; Chung HY
Biosci Biotechnol Biochem; 2006 Feb; 70(2):532-4. PubMed ID: 16495675
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of cinnamic amide derivatives and their anti-melanogenic effect in α-MSH-stimulated B16F10 melanoma cells.
Ullah S; Kang D; Lee S; Ikram M; Park C; Park Y; Yoon S; Chun P; Moon HR
Eur J Med Chem; 2019 Jan; 161():78-92. PubMed ID: 30347330
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of 2-(substituted phenyl)thiazolidine-4-carboxylic acid derivatives as novel tyrosinase inhibitors.
Ha YM; Park YJ; Lee JY; Park D; Choi YJ; Lee EK; Kim JM; Kim JA; Park JY; Lee HJ; Moon HR; Chung HY
Biochimie; 2012 Feb; 94(2):533-40. PubMed ID: 21945595
[TBL] [Abstract][Full Text] [Related]
15. A novel adamantyl benzylbenzamide derivative, AP736, suppresses melanogenesis through the inhibition of cAMP-PKA-CREB-activated microphthalmia-associated transcription factor and tyrosinase expression.
Lee CS; Jang WH; Park M; Jung K; Baek HS; Joo YH; Park YH; Lim KM
Exp Dermatol; 2013 Nov; 22(11):762-4. PubMed ID: 24107097
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Novel Synthetic Tyrosinase Inhibitor (
Bang E; Noh SG; Ha S; Jung HJ; Kim DH; Lee AK; Hyun MK; Kang D; Lee S; Park C; Moon HR; Chung HY
Molecules; 2018 Dec; 23(12):. PubMed ID: 30551624
[TBL] [Abstract][Full Text] [Related]
17. The hypopigmentary action of KI-063 (a new tyrosinase inhibitor) combined with terrein.
Kim DS; Lee S; Lee HK; Park SH; Ryoo IJ; Yoo ID; Kwon SB; Baek KJ; Na JI; Park KC
J Pharm Pharmacol; 2008 Mar; 60(3):343-8. PubMed ID: 18284814
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of melanogenesis by 2-[4-(5-chlorobenzo[d]thiazol-2-yl)phenoxy]-2-methylpropanoic acid (MHY908).
Park MH; Kim SJ; Jeong HO; Moon KM; Son S; Kim DH; Kim HR; Kim MJ; Yun HY; Chun P; Je NK; Yokozawa T; Moon HR; Chung HY
Arch Pharm Res; 2015 Apr; 38(4):505-11. PubMed ID: 25502981
[TBL] [Abstract][Full Text] [Related]
19. Sargaquinoic acid ameliorates hyperpigmentation through cAMP and ERK-mediated downregulation of MITF in α-MSH-stimulated B16F10 cells.
Azam MS; Kwon M; Choi J; Kim HR
Biomed Pharmacother; 2018 Aug; 104():582-589. PubMed ID: 29803170
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and anti-melanogenic effects of (E)-2-benzoyl-3-(substituted phenyl)acrylonitriles.
Yun HY; Kim DH; Son S; Ullah S; Kim SJ; Kim YJ; Yoo JW; Jung Y; Chun P; Moon HR
Drug Des Devel Ther; 2015; 9():4259-68. PubMed ID: 26347064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
